Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
03/22/2023 | Allogene Therapeutics, Inc. | ALLO | Grant | Stock Option (Right to buy) | 432.7k | $5.04 | $2.2M | | 03/22/2023 |
03/22/2023 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 558.1k | $0.00 | $0 | | 03/22/2023 |
03/14/2023 | Allogene Therapeutics, Inc. | ALLO | Payment of Exercise | Common Stock | 8.4k | $5.51 | $46k | | 03/14/2023 |
03/23/2022 | Allogene Therapeutics, Inc. | ALLO | Grant | Stock Option (Right to Buy) | 737.2k | $9.69 | $7.1M | | 03/23/2022 |
03/15/2022 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 8.7k | $7.63 | $66.4k | | 03/15/2022 |
06/15/2021 | CODEXIS, INC. | CDXS | Grant | Common Stock | 4.8k | $0.00 | $0 | | 06/15/2021 |
03/26/2021 | Allogene Therapeutics, Inc. | ALLO | Grant | Stock Option (Right to Buy) | 92.4k | $33.78 | $3.1M | | 03/26/2021 |
03/26/2021 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 24.9k | $0.00 | $0 | | 03/26/2021 |
03/15/2021 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 6.2k | $38.14 | $235.1k | | 03/15/2021 |
10/13/2020 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 11k | $42.00 | $463.3k | | 10/12/2020 |
10/13/2020 | Allogene Therapeutics, Inc. | ALLO | Exercise | Stock Option (Right to Buy) | 11k | $2.27 | $25k | | 10/12/2020 |
10/12/2020 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 24.2k | $42.00 | $1M | | 10/12/2020 |
10/12/2020 | Allogene Therapeutics, Inc. | ALLO | Exercise | Stock Option (Right to Buy) | 24.2k | $2.27 | $55k | | 10/12/2020 |
10/09/2020 | Allogene Therapeutics, Inc. | ALLO | Exercise | Stock Option (Right to Buy) | 30.2k | $2.27 | $68.6k | | 10/08/2020 |
10/09/2020 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 39.5k | $41.00 | $1.6M | | 10/08/2020 |
10/08/2020 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 5.1k | $41.00 | $207.7k | | 10/08/2020 |
10/08/2020 | Allogene Therapeutics, Inc. | ALLO | Exercise | Stock Option (Right to Buy) | 5.1k | $2.27 | $11.5k | | 10/08/2020 |
10/06/2020 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 44.6k | $40.00 | $1.8M | | 10/06/2020 |
10/06/2020 | Allogene Therapeutics, Inc. | ALLO | Exercise | Stock Option (Right to Buy) | 35.3k | $2.27 | $80k | | 10/06/2020 |
08/13/2020 | Allogene Therapeutics, Inc. | ALLO | Exercise | Stock Option (Right to Buy) | 32.5k | $2.27 | $73.7k | | 08/13/2020 |
06/16/2020 | CODEXIS, INC. | CDXS | Grant | Common Stock | 17.9k | $0.00 | $0 | | 06/16/2020 |
03/18/2020 | Allogene Therapeutics, Inc. | ALLO | Grant | Stock Option (Right to Buy) | 109.6k | $18.22 | $2M | | 03/18/2020 |
03/18/2020 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 30.8k | $0.00 | $0 | | 03/18/2020 |
03/16/2020 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 3.8k | $19.19 | $72k | | 03/16/2020 |
09/18/2019 | Allogene Therapeutics, Inc. | ALLO | Exercise | Stock Option (Right to Buy) | 21.1k | $2.27 | $47.8k | | 09/16/2019 |
09/18/2019 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 21.1k | $32.13 | $676.9k | | 09/16/2019 |
09/17/2019 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 22.5k | $32.11 | $722.6k | | 09/16/2019 |
09/17/2019 | Allogene Therapeutics, Inc. | ALLO | Exercise | Stock Option (Right to Buy) | 22.5k | $2.27 | $51.1k | | 09/16/2019 |
09/16/2019 | Allogene Therapeutics, Inc. | ALLO | Exercise | Stock Option (Right to Buy) | 5.3k | $2.27 | $11.9k | | 09/16/2019 |
09/16/2019 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 5.3k | $32.00 | $168.2k | | 09/16/2019 |
07/30/2019 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 11.8k | $29.85 | $352.7k | | 07/26/2019 |
07/30/2019 | Allogene Therapeutics, Inc. | ALLO | Exercise | Stock Option (Right to Buy) | 11.8k | $2.27 | $26.8k | | 07/26/2019 |
07/29/2019 | Allogene Therapeutics, Inc. | ALLO | Exercise | Stock Option (Right to Buy) | 23.8k | $2.27 | $54.1k | | 07/26/2019 |
07/29/2019 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 23.8k | $29.39 | $699.9k | | 07/26/2019 |
07/26/2019 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 13.2k | $29.18 | $385k | | 07/26/2019 |
|